Structure

InChI Key FBSKJMQYURKNSU-ZLSOWSIRSA-N
Smile C[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@H](OCCc3ccc(O)c(O)c3)O[C@H](CO)[C@H]2OC(=O)/C=C/c2ccc(O)c(O)c2)[C@H](O)[C@H](O)[C@H]1O
InChI
InChI=1S/C29H36O15/c1-13-22(36)23(37)24(38)29(41-13)44-27-25(39)28(40-9-8-15-3-6-17(32)19(34)11-15)42-20(12-30)26(27)43-21(35)7-4-14-2-5-16(31)18(33)10-14/h2-7,10-11,13,20,22-34,36-39H,8-9,12H2,1H3/b7-4+/t13-,20+,22-,23+,24+,25+,26+,27+,28+,29-/m0/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C29H36O15
Molecular Weight 624.59
AlogP -1.02
Hydrogen Bond Acceptor 15.0
Hydrogen Bond Donor 9.0
Number of Rotational Bond 10.0
Polar Surface Area 245.29
Molecular species NEUTRAL
Aromatic Rings 2.0
Heavy Atoms 44.0

Pharmacology

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Glomerulonephritis, IGA 2 D005922 ClinicalTrials

Related Entries

Scaffolds

Cross References

Resources Reference
ChEBI 132853
ChEMBL CHEMBL444478
DrugBank DB12996
FDA SRS 3TGX09BD5B
KEGG C10501
SureChEMBL SCHEMBL657970
ZINC ZINC000008234351